These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28833361)

  • 21. Nuclear Sensor Interferon-Inducible Protein 16 Inhibits the Function of Hepatitis B Virus Covalently Closed Circular DNA by Integrating Innate Immune Activation and Epigenetic Suppression.
    Yang Y; Zhao X; Wang Z; Shu W; Li L; Li Y; Guo Z; Gao B; Xiong S
    Hepatology; 2020 Apr; 71(4):1154-1169. PubMed ID: 31402464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control and Eradication Strategies of Hepatitis B Virus.
    Shih C; Chou SF; Yang CC; Huang JY; Choijilsuren G; Jhou RS
    Trends Microbiol; 2016 Sep; 24(9):739-749. PubMed ID: 27287929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus.
    Moyo B; Bloom K; Scott T; Ely A; Arbuthnot P
    Virus Res; 2018 Jan; 244():311-320. PubMed ID: 28087399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of Hepatitis B Virus cccDNA Formation.
    Wei L; Ploss A
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.
    Zhang Y; Mao R; Yan R; Cai D; Zhang Y; Zhu H; Kang Y; Liu H; Wang J; Qin Y; Huang Y; Guo H; Zhang J
    PLoS One; 2014; 9(10):e110442. PubMed ID: 25337821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases.
    Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J
    Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the Interactions of HBV cccDNA with Host Factors.
    Mohd-Ismail NK; Lim Z; Gunaratne J; Tan YJ
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of Hepatitis B Virus Nuclear DNA.
    Li M; Sohn JA; Seeger C
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
    Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
    Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological Basis for the Cure of Chronic Hepatitis B.
    Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
    ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the Heterogeneity of Histone Modifications on Hepatitis B Virus DNA Using Liver Needle Biopsies Obtained from Chronically Infected Patients.
    Flecken T; Meier MA; Skewes-Cox P; Barkan DT; Heim MH; Wieland SF; Holdorf MM
    J Virol; 2019 May; 93(9):. PubMed ID: 30787147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA.
    Ahmed M; Wang F; Levin A; Le C; Eltayebi Y; Houghton M; Tyrrell L; Barakat K
    Drug Discov Today; 2015 May; 20(5):548-61. PubMed ID: 25622780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation profile of hepatitis B virus is not influenced by interferon α in human liver cancer cells.
    Moon IY; Kim JW
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The current status and future directions of hepatitis B antiviral drug discovery.
    Tang L; Zhao Q; Wu S; Cheng J; Chang J; Guo JT
    Expert Opin Drug Discov; 2017 Jan; 12(1):5-15. PubMed ID: 27797587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Luo X; Huang Y; Chen Y; Tu Z; Hu J; Tavis JE; Huang A; Hu Y
    PLoS One; 2016; 11(6):e0157708. PubMed ID: 27310677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription.
    Yu X; Long Q; Shen S; Liu Z; Chandran J; Zhang J; Ding H; Zhang H; Cai D; Kim ES; Huang Y; Guo H
    Antiviral Res; 2023 Mar; 211():105552. PubMed ID: 36737008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.
    Tropberger P; Mercier A; Robinson M; Zhong W; Ganem DE; Holdorf M
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5715-24. PubMed ID: 26438841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
    Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
    J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.